A microRNA code for prostate cancer metastasis

Although the development of bone metastasis is a major detrimental event in prostate cancer, the molecular mechanisms responsible for bone homing and destruction remain largely unknown. Here we show that loss of miR-15 and miR-16 in cooperation with increased miR-21 expression promote prostate cancer spreading and bone lesions. This combination of microRNA endows bone-metastatic potential to prostate cancer cells. Concomitant loss of miR-15/miR-16 and gain of miR-21 aberrantly activate TGF-β and Hedgehog signaling, that mediate local invasion, distant bone marrow colonization and osteolysis by prostate cancer cells. These findings establish a new molecular circuitry for prostate cancer metastasis that was validated in patients' cohorts. Our data indicate a network of biomarkers and druggable pathways to improve patient treatment.

[1]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[2]  J. Massagué,et al.  TGFβ in Cancer , 2008, Cell.

[3]  J. Trent,et al.  α-methylacyl-CoA racemase: A new molecular marker for prostate cancer , 2002 .

[4]  H. Prats,et al.  The VEGF IRESes are differentially susceptible to translation inhibition by miR-16. , 2009, RNA.

[5]  X. Yao,et al.  Serum miRNA‐21: Elevated levels in patients with metastatic hormone‐refractory prostate cancer and potential predictive factor for the efficacy of docetaxel‐based chemotherapy , 2011, The Prostate.

[6]  George A Calin,et al.  MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. , 2009, Cancer research.

[7]  Haoming Zhang,et al.  miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes , 2008, Nucleic acids research.

[8]  B. Teicher.  Malignant Cells, Directors of the Malignant Process: Role of Transforming Growth Factor-beta , 2004, Cancer and Metastasis Reviews.

[9]  Mauro Biffoni,et al.  The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities , 2008, Nature Medicine.

[10]  C. Logothetis,et al.  Osteoblasts in prostate cancer metastasis to bone , 2005, Nature Reviews Cancer.

[11]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[12]  G. Muto,et al.  BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial–mesenchymal transition , 2013, Oncogene.

[13]  C. Croce,et al.  miR-15a and miR-16-1 in cancer: discovery, function and future perspectives , 2010, Cell Death and Differentiation.

[14]  R. Samant,et al.  Hedgehog Signaling in Tumor Cells Facilitates Osteoblast-Enhanced Osteolytic Metastases , 2012, PloS one.

[15]  Anna M. Krichevsky,et al.  miR-21: a small multi-faceted RNA , 2008, Journal of cellular and molecular medicine.

[16]  M. D'Esposito,et al.  An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation , 2009, Oncogene.

[17]  M. Clarke,et al.  Stem Cells and Cancer: Two Faces of Eve , 2006, Cell.

[18]  L. Ricci-Vitiani,et al.  Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.

[19]  E. Wentzel,et al.  miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth. , 2009, Cancer research.

[20]  P. Sánchez,et al.  Therapeutic targeting of the Hedgehog-GLI pathway in prostate cancer. , 2005, Cancer research.

[21]  J. Weidhaas,et al.  Cancer microRNAs: from subtype profiling to predictors of response to therapy. , 2011, Trends in molecular medicine.

[22]  G. Dontu,et al.  Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. , 2006, Cancer research.

[23]  Leonardo Morsut,et al.  FAM/USP9x, a Deubiquitinating Enzyme Essential for TGFβ Signaling, Controls Smad4 Monoubiquitination , 2009, Cell.

[24]  J. Waxman,et al.  Bone metastasis in prostate cancer: emerging therapeutic strategies , 2011, Nature Reviews Clinical Oncology.

[25]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[26]  G. Calin,et al.  MicroRNAs in body fluids—the mix of hormones and biomarkers , 2011, Nature Reviews Clinical Oncology.

[27]  M. Datta,et al.  Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Soonmyung Paik,et al.  Gene-expression-based prognostic assays for breast cancer , 2010, Nature Reviews Clinical Oncology.

[29]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[30]  R. Weinberg,et al.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.

[31]  Mohammed Azmi Al-Betar,et al.  comprehensive review : Krill Herd algorithm ( KH ) and its pplications saju , 2016 .

[32]  T. Guise,et al.  Cancer to bone: a fatal attraction , 2011, Nature Reviews Cancer.

[33]  A. Mauviel,et al.  Crosstalk between TGF‐β and hedgehog signaling in cancer , 2012, FEBS letters.

[34]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[35]  C. Heldin,et al.  Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. , 1997, Nature.

[36]  C. Heldin,et al.  Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling , 1997, Nature.

[37]  Tsung-Cheng Chang,et al.  Widespread microRNA repression by Myc contributes to tumorigenesis , 2008, Nature Genetics.

[38]  C. Sander,et al.  Integrative genomic profiling of human prostate cancer. , 2010, Cancer cell.

[39]  M. Ceccarelli,et al.  Upregulation of miR-21 by Ras in vivo and its role in tumor growth , 2011, Oncogene.

[40]  K. Miyazono,et al.  Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. , 2009, Cell stem cell.

[41]  T. Shibata,et al.  TGF-β regulates isoform switching of FGF receptors and epithelial–mesenchymal transition , 2011, The EMBO journal.

[42]  S. Newfeld,et al.  Fat facets deubiquitylation of Medea/Smad4 modulates interpretation of a Dpp morphogen gradient , 2012, Development.

[43]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[44]  G. Mundy.  Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities , 2002, Nature Reviews Cancer.

[45]  Kenneth M. Yamada,et al.  Modeling Tissue Morphogenesis and Cancer in 3D , 2007, Cell.

[46]  M. Kattan,et al.  Association of Pre- and Postoperative Plasma Levels of Transforming Growth Factor β1 and Interleukin 6 and Its Soluble Receptor with Prostate Cancer Progression , 2004, Clinical Cancer Research.

[47]  C. Croce,et al.  MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review , 2012, EMBO molecular medicine.

[48]  F. Saad,et al.  Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial , 2012, The Lancet.

[49]  M. Petz,et al.  The crosstalk of RAS with the TGF-β family during carcinoma progression and its implications for targeted cancer therapy. , 2010, Current cancer drug targets.

[50]  H. Hermeking,et al.  Metastasis in Colorectal Cancer Mesenchymal Transition and − Feedback Loop to Regulate Epithelial p 53-Induced miR-15 a / 16-1 and AP 4 Form a Double-Negative , 2014 .

[51]  M. Valtieri,et al.  The mesenchymal stromal cell contribution to homeostasis , 2008, Journal of cellular physiology.

[52]  Uyen Tran,et al.  MicroRNA control of Nodal signalling , 2007, Nature.

[53]  N. Kaminski,et al.  miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis , 2010 .

[54]  M. Biffoni,et al.  Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. , 2008, Experimental hematology.

[55]  K. Miyazono,et al.  Roles of TGF-β family signaling in stem cell renewal and differentiation , 2009, Cell Research.

[56]  G. Stein,et al.  Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone , 2006, Cancer and Metastasis Reviews.

[57]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[58]  A. Mauviel,et al.  Overlapping activities of TGF-β and Hedgehog signaling in cancer: therapeutic targets for cancer treatment. , 2013, Pharmacology & therapeutics.

[59]  Sherry L. Werner,et al.  Blockade of transforming growth factor‐beta (TGFβ) signaling inhibits osteoblastic tumorigenesis by a novel human prostate cancer cell line , 2011, The Prostate.

[60]  A. Hata,et al.  SMAD proteins control DROSHA-mediated microRNA maturation , 2008, Nature.

[61]  Thomas Kirchner,et al.  p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer. , 2014, Cancer research.

[62]  Shafiq A. Khan,et al.  Expression of nodal and nodal receptors in prostate stem cells and prostate cancer cells: Autocrine effects on cell proliferation and migration , 2011, The Prostate.

[63]  G. Muto,et al.  Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer , 2011, Oncogene.

[64]  Andrea Califano,et al.  The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. , 2010, Cancer cell.

[65]  E. Olson,et al.  Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. , 2010, Cancer cell.

[66]  S. Memarzadeh,et al.  Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation. , 2010, Cell stem cell.

[67]  M. Hendrix,et al.  Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells , 2011, The Prostate.

[68]  S. Bicciato,et al.  The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells , 2011, Cell.

[69]  William Elison,et al.  Line , 2017, The Craft of Poetry.

[70]  George A. Calin,et al.  MicroRNAs — the micro steering wheel of tumour metastases , 2009, Nature Reviews Cancer.